Covered recipient · General Payments record
MIRIAM P CUMMINGS
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$3,406.89
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,079.17 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $468.93 | 18 |
| REVANCE THERAPEUTICS, INC. | $390.88 | 5 |
| Amgen Inc. | $219.36 | 4 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.68 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521692 | CMS |
| ABBVIE INC. | $16.84 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521694 | CMS |
| ABBVIE INC. | $4.84 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521696 | CMS |
| ABBVIE INC. | $13.91 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521698 | CMS |
| ABBVIE INC. | $26.39 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521700 | CMS |
| ABBVIE INC. | $12.11 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521702 | CMS |
| ABBVIE INC. | $33.41 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521704 | CMS |
| ABBVIE INC. | $4.83 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521706 | CMS |
| ABBVIE INC. | $12.86 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521708 | CMS |
| ABBVIE INC. | $11.60 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521710 | CMS |
| ABBVIE INC. | $5.21 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521712 | CMS |
| ABBVIE INC. | $21.72 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521714 | CMS |
| ABBVIE INC. | $135.68 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521716 | CMS |
| ABBVIE INC. | $21.59 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521718 | CMS |
| ABBVIE INC. | $13.22 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521720 | CMS |
| ABBVIE INC. | $23.12 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521722 | CMS |
| ABBVIE INC. | $74.90 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521724 | CMS |
| ABBVIE INC. | $26.02 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103521726 | CMS |
| Amgen Inc. | $104.99 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117534462 | CMS |
| Amgen Inc. | $35.17 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117534464 | CMS |
| Amgen Inc. | $37.62 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117534466 | CMS |
| Amgen Inc. | $41.58 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117534468 | CMS |
| REVANCE THERAPEUTICS, INC. | $19.73 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147915499 | CMS |
| REVANCE THERAPEUTICS, INC. | $30.42 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147915501 | CMS |
| REVANCE THERAPEUTICS, INC. | $148.18 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147915503 | CMS |
| REVANCE THERAPEUTICS, INC. | $131.34 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147915505 | CMS |
| REVANCE THERAPEUTICS, INC. | $61.21 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147915507 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.